{"AllianceGenome": "2338", "HGNC": "2338", "MIM": "180230", "_id": "1381", "_version": 1, "accession": {"genomic": ["AC011270.9", "CH471136.2", "CP068263.2", "FB571429.1", "NC_000015.10", "NC_060939.1"], "protein": ["AAB20773.1", "AAH22069.1", "BAJ84031.1", "CAG33298.1", "CAR95132.1", "EAW99172.1", "NP_004369.1", "P29762.2"], "rna": ["AB593091.1", "AI863257.1", "AL110113.1", "AU132726.1", "BC022069.1", "CR457017.1", "NM_004378.3", "S74445.1"], "translation": [{"protein": "NP_004369.1", "rna": "NM_004378.3"}, {"protein": "AAB20773.1", "rna": "S74445.1"}, {"protein": "BAJ84031.1", "rna": "AB593091.1"}, {"protein": "CAG33298.1", "rna": "CR457017.1"}, {"protein": "AAH22069.1", "rna": "BC022069.1"}]}, "alias": ["CRABP", "CRABP-I", "CRABPI", "RBP5"], "ensembl": {"gene": "ENSG00000166426", "protein": ["ENSP00000299529", "ENSP00000385978"], "transcript": ["ENST00000299529", "ENST00000406419", "ENST00000560753"], "translation": [{"protein": "ENSP00000299529", "rna": "ENST00000299529"}, {"protein": "ENSP00000385978", "rna": "ENST00000406419"}], "type_of_gene": "protein_coding"}, "entrezgene": "1381", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 5.20572895644, "exp_mis": 61.5126196161, "exp_syn": 34.3616004017, "lof_z": 1.39179636245233, "mis_z": 1.65343430065662, "mu_lof": 3.67378093466e-07, "mu_mis": 6.33178913322e-06, "mu_syn": 3.4599450218e-06, "n_lof": 2.0, "n_mis": 35.0, "n_syn": 28.0, "p_li": 0.12550489400582, "p_null": 0.0944130142132061, "p_rec": 0.780082091780974, "syn_z": 0.672789418238345}, "bp": 414, "cds_end": 78640319, "cds_start": 78632770, "n_exons": 4, "nonpsych": {"exp_lof": 4.63995647395, "exp_mis": 55.6031275731, "exp_syn": 31.0288387236, "lof_z": 1.20362681142842, "mis_z": 1.79947089965736, "mu_lof": 3.67378093466e-07, "mu_mis": 6.33178913322e-06, "mu_syn": 3.4599450218e-06, "n_lof": 2.0, "n_mis": 29.0, "n_syn": 29.0, "p_li": 0.113514784478806, "p_null": 0.125285181813412, "p_rec": 0.761200033707781, "syn_z": 0.229312950768703}, "nontcga": {"exp_lof": 4.78227893379, "exp_mis": 56.5846222478, "exp_syn": 31.6056870122, "lof_z": 1.25505983920197, "mis_z": 1.49579968418805, "mu_lof": 3.67378093466e-07, "mu_mis": 6.33178913322e-06, "mu_syn": 3.4599450218e-06, "n_lof": 2.0, "n_mis": 34.0, "n_syn": 20.0, "p_li": 0.11122081814436, "p_null": 0.111200007793161, "p_rec": 0.777579174062479, "syn_z": 1.30710545647943}, "transcript": "ENST00000299529.6"}, "exons": [{"cdsend": 78347977, "cdsstart": 78340428, "chr": "15", "position": [[78340352, 78340498], [78341042, 78341221], [78343498, 78343612], [78347926, 78348225]], "strand": 1, "transcript": "NM_004378", "txend": 78348225, "txstart": 78340352}], "exons_hg19": [{"cdsend": 78640319, "cdsstart": 78632770, "chr": "15", "position": [[78632694, 78632840], [78633384, 78633563], [78635840, 78635954], [78640268, 78640567]], "strand": 1, "transcript": "NM_004378", "txend": 78640567, "txstart": 78632694}], "generif": [{"pubmed": 12640681, "text": "Loss of cellular retinoic acid binding protein 1 function due to hypermethylation of its promoter leads to pathogenesis of papillary thyroid carcinoma"}, {"pubmed": 14605320, "text": "CSF of Moyamoya Disease [MMD] patients reveals high CRABP-I expression suggesting that the elevation of CRABP-I in CSF may be a candidate for pathogenesis of MMD"}, {"pubmed": 14713576, "text": "CRABP I plays an important role not only in mediating the retinoid effects, but also in modulating the radiation sensitivity of tumour cells after combined retinoic acid radiation treatment."}, {"pubmed": 15281009, "text": "increased CYP26-mediated catabolism of retinoic by CRABP-I transfection might decrease the amount of retinoic acid that is accessible to the nuclear receptors"}, {"pubmed": 15515157, "text": "Decreases in the CRABP1 (cellular retinoic acid binding protein 1) and TFF3 (trefoil factor 3) expression levels identified these as candidate molecular biomarkers for papillary thyroid carcinoma."}, {"pubmed": 16254461, "text": "Real-time RT-PCR analysis disclosed a significant lack of CRABP-I expression in four renal cell carcinoma cell lines"}, {"pubmed": 17167179, "text": "Hypermethylation was subsequently identified for three of four analyzed genes, ADAMTS1 (85%), CRABP1 (90%), and NR3C1 (35%)."}, {"pubmed": 17438526, "text": "Frequent methylation-associated silencing of CRABP1 is associated with esophageal squamous-cell carcinoma"}, {"pubmed": 17623056, "text": "DNA hypermethylation of tumour suppressor genes seems to play an important role in ovarian carcinogenesis and HOXA9, HOXB5, SCGB3A1, and CRABP1 are identified as novel hypermethylated target genes in this tumour type"}, {"pubmed": 17727842, "text": "As epidermal basal keratinocyte proliferation is stimulated by paracrine growth factors secreted by ATRA activated suprabasal keratinocytes, our results indicate that CRABPI overexpression in suprabasal keratinocytes enhances ATRA."}, {"pubmed": 18000064, "text": "supports an active role for PLZF and RARalpha-PLZF in leukemogenesis, identifies up-regulation of CRABPI"}, {"pubmed": 19087254, "text": "The authors identified several dysregulated genes and proteins, but only the cellular retinoic acid binding protein 1 (CRABP1) was up-regulated exclusively in cells expressing an increased Abeta42/Abeta40 ratio."}, {"pubmed": 20571827, "text": "reduced expression of CRABP1 has a potential as a prognostic marker for serous adenocarcinoma which is the most frequent histological ovarian tumor type and also for clear cell carcinoma that often exhibits chemo-resistance."}, {"pubmed": 20571834, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20634891, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21270509, "text": "Results describe the mRNA expression of CRABP1, RERG, and GRP in pituitary adenomas."}, {"pubmed": 24269351, "text": "Factors involved in the retinoid pathway, in particular upregulation of CRBP, CRABP1 and CRABP2, also showed differential expression in tumors with different histological subtypes"}, {"pubmed": 24626200, "text": "the first evidence of pro-tumorigenic and pro-metastatic activity of CRABP1 in mesenchymal and neuroendocrine tumors."}, {"pubmed": 25034531, "text": "we demonstrated significant changes in CRABP1 and CRABP2 expression in non-small cell lung cancer samples"}, {"pubmed": 26124181, "text": "miR-93/miR-106b/miR-375-CIC-CRABP1 is a novel key regulatory axis in prostate cancer progression"}, {"pubmed": 26142905, "text": "CRABP1 expression is maintained in ER- and triple-negative breast tumors, and that elevated levels of CRABP1 is a significant indicator of high tumor grade, Ki67 immunoreactivity, and poor prognosis."}, {"pubmed": 26843908, "text": "p75NTR and CRABP1 modulate the effect of fenretinide on neuroblastoma cells"}, {"pubmed": 27416800, "text": "Holo-CRABPs had higher affinity for CYP26B1 than free atRA, but both apo-CRABPs(CRABP-I and CRABP-II ) inhibited the formation of 4-OH-RA by CYP26B1."}, {"pubmed": 29321030, "text": "We conclude that the underexpression of CRABP1 and the overexpression of LCN2 may be useful diagnostic biomarkers in thyroid tumours with questionable malignity, and the overexpression of LCN2 and C1QL1 may be useful for prognostic purposes."}, {"pubmed": 30728260, "text": "Regulation of Hepatitis C Virus Infection by Cellular Retinoic Acid Binding Proteins through the Modulation of Lipid Droplet Abundance."}, {"pubmed": 31344789, "text": "These are supported by the fact that CRABP1 gene knockout (KO) mice exhibit multiple phenotypes including hippocampal NSC expansion and spontaneous cardiac hypertrophy. This indicates that more potential processes/signaling pathways involving atRA-CRABP1 may exist, which remain to be identified."}, {"pubmed": 32013828, "text": "Cellular Retinoic-Acid Binding Protein 2 in Solid Tumor."}, {"pubmed": 32527063, "text": "Sonic Hedgehog-Gli1 Signaling and Cellular Retinoic Acid Binding Protein 1 Gene Regulation in Motor Neuron Differentiation and Diseases."}, {"pubmed": 33832420, "text": "CRABP1 and CRABP2 Protein Levels Correlate with Each Other but Do Not Correlate with Sensitivity of Breast Cancer Cells to Retinoic Acid."}, {"pubmed": 35417033, "text": "Expression of cellular retinoic acid binding protein 1 predicts peritoneal recurrence of gastric cancer."}], "genomic_pos": {"chr": "15", "end": 78348225, "ensemblgene": "ENSG00000166426", "start": 78340353, "strand": 1}, "genomic_pos_hg19": {"chr": "15", "end": 78640572, "start": 78632666, "strand": 1}, "go": {"BP": [{"evidence": "TAS", "gocategory": "BP", "id": "GO:0007165", "pubmed": 1309505, "qualifier": "involved_in", "term": "signal transduction"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0015908", "qualifier": "involved_in", "term": "fatty acid transport"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "is_active_in", "term": "nucleus"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "is_active_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0001972", "qualifier": "enables", "term": "retinoic acid binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0005501", "pubmed": 1309505, "qualifier": "enables", "term": "retinoid binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0005504", "qualifier": "enables", "term": "fatty acid binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [15607035, 32296183, 35156780], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0016918", "qualifier": "enables", "term": "retinal binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0019841", "qualifier": "enables", "term": "retinol binding"}]}, "homologene": {"genes": [[7955, 171479], [7955, 415102], [8364, 100496464], [9031, 374211], [9544, 710048], [9598, 740693], [9606, 1381], [9913, 282201], [10090, 12903], [10116, 25061]], "id": 3222}, "interpro": [{"desc": "Cytosolic fatty-acid binding", "id": "IPR000463", "short_desc": "Fatty_acid-bd"}, {"desc": "Lipocalin/cytosolic fatty-acid binding domain", "id": "IPR000566", "short_desc": "Lipocln_cytosolic_FA-bd_dom"}, {"desc": "Calycin", "id": "IPR012674", "short_desc": "Calycin"}, {"desc": "Intracellular lipid binding protein", "id": "IPR031259", "short_desc": "ILBP"}], "ipi": ["IPI00219930", "IPI00796739"], "map_location": "15q25.1", "name": "cellular retinoic acid binding protein 1", "other_names": ["cellular retinoic acid-binding protein 1", "cellular retinoic acid-binding protein I"], "pantherdb": {"HGNC": "2338", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "88490", "ortholog_type": "LDO", "panther_family": "PTHR11955", "taxid": 10090, "uniprot_kb": "P62965"}, {"RGD": "2400", "ortholog_type": "LDO", "panther_family": "PTHR11955", "taxid": 10116, "uniprot_kb": "P62966"}, {"Ensembl": "ENSGALG00000003193", "ortholog_type": "LDO", "panther_family": "PTHR11955", "taxid": 9031, "uniprot_kb": "P40220"}, {"ZFIN": "ZDB-GENE-040624-3", "ortholog_type": "O", "panther_family": "PTHR11955", "taxid": 7955, "uniprot_kb": "Q6IWJ1"}, {"ZFIN": "ZDB-GENE-020320-3", "ortholog_type": "LDO", "panther_family": "PTHR11955", "taxid": 7955, "uniprot_kb": "E9QD41"}, {"WormBase": "WBGene00021486", "ortholog_type": "O", "panther_family": "PTHR11955", "taxid": 6239, "uniprot_kb": "Q965W1"}, {"WormBase": "WBGene00002260", "ortholog_type": "O", "panther_family": "PTHR11955", "taxid": 6239, "uniprot_kb": "O02324"}, {"WormBase": "WBGene00002259", "ortholog_type": "O", "panther_family": "PTHR11955", "taxid": 6239, "uniprot_kb": "O02323"}, {"WormBase": "WBGene00002257", "ortholog_type": "O", "panther_family": "PTHR11955", "taxid": 6239, "uniprot_kb": "O01814"}, {"WormBase": "WBGene00002258", "ortholog_type": "O", "panther_family": "PTHR11955", "taxid": 6239, "uniprot_kb": "O01812"}, {"FlyBase": "FBgn0037913", "ortholog_type": "O", "panther_family": "PTHR11955", "taxid": 7227, "uniprot_kb": "Q8INK3"}], "uniprot_kb": "P29762"}, "pathway": {"reactome": [{"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-5362517", "name": "Signaling by Retinoic Acid"}, {"id": "R-HSA-5365859", "name": "RA biosynthesis pathway"}, {"id": "R-HSA-9006931", "name": "Signaling by Nuclear Receptors"}], "wikipathways": [{"id": "WP4255", "name": "Non-small cell lung cancer"}, {"id": "WP716", "name": "Vitamin A and carotenoid metabolism"}]}, "pdb": ["7A9Y", "7A9Z"], "pfam": "PF00061", "pharmgkb": "PA26858", "pharos": {"target_id": 2878, "tdl": "Tbio"}, "pir": "JH0548", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF167501", "relationship": "is"}, {"id": "GNF178407", "relationship": "is"}, {"id": "GNF189313", "relationship": "is"}, {"id": "GNF200219", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF160601", "relationship": "is"}, "GNF_mm+hs-MGC": {"id": "GNF002951", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF097612", "relationship": "is"}, {"id": "GNF137267", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000015.10", "NC_060939.1"], "protein": "NP_004369.1", "rna": "NM_004378.3", "translation": {"protein": "NP_004369.1", "rna": "NM_004378.3"}}, "reporter": {"HG-U133_Plus_2": ["1563897_at", "205350_at"], "HG-U95Av2": ["542_at", "543_g_at"], "HG-U95B": "49212_at", "HTA-2_0": "TC15000728.hg.1", "HuEx-1_0": ["3603295", "3634633"], "HuGene-1_1": ["7985159", "7990712"], "HuGene-2_1": "16803492"}, "summary": "This gene encodes a specific binding protein for a vitamin A family member and is thought to play an important role in retinoic acid-mediated differentiation and proliferation processes. It is structurally similar to the cellular retinol-binding proteins, but binds only retinoic acid at specific sites within the nucleus, which may contribute to vitamin A-directed differentiation in epithelial tissue. [provided by RefSeq, Jul 2008].", "symbol": "CRABP1", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1413697"}, "unigene": "Hs.346950", "uniprot": {"Swiss-Prot": "P29762", "TrEMBL": ["B5MCB5", "F1T0F7"]}, "wikipedia": {"url_stub": "CRABP1"}}